References
- Revised Reregistration Eligibility Decision for MSMA, DSMA, CAMA, and Cacodylic Acid. United States Environmental Protection Agency. Washington, DC, 2006, EPA 738-R-06-021.
- Environmental Protection Agency. Organic arsenicals; product cancellation order and amendment to terminate uses. Fed Reg 2009; 74(188):50187–50194.
- Kales SN, Huyck KL, Goldman RH. Elevated urine arsenic: un-speciated results lead to unnecessary concern and further evaluations. J Anal Toxicol 2006; 30:80–85.
- Gentry NL, Crumpston K, Rose SR. Direct cardiotoxicity from an acute pentavalent arsenic ingestion. Clin Toxicol 2009; 47:737.
- Shum S, Whithead J, Vaughn L, Shum S, Hale T. Chelation of organoarsonate with dimercaptosuccinic acid. Vet Human Toxicol 1995; 37:239–242.
- Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002; 181–182:211–217.
- Aposhian HV, Zakharyan RA, Avram MD, Kopplin MJ, Wollenberg ML. Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharm 2003; 193:1–8.
- Buchet JP, Lauwerys, R, Roels H. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 1981; 48:71–79.
- Majlesa N, Lee DC, Chan GM, McGuigan MA, Caraccio TC, Su MK, Greller HA. Minimal sequelae after large ingestion of arsenic herbicide. Clin Toxicol 2009; 47:761.
- Schwartz E, Roth B, Feng SY, Wax PM. Pediatric monosodium methylarsonate exposure with significantly elevated urinary arsenic levels. Clin Toxicol 2010; 48:623.
- Peoples SA, Maddy KT, Peifer WR, Edminston S. Occupational exposures to pesticides containing organoarsenicals in California. Vet Hum Toxicol 1979; 21:417–421.
- Hessl SM, Berman E. Severe peripheral neuropathy after exposure to monosodium methyl arsonate. J Toxicol Clin Toxicol 1982; 19: 281–287.